Three-Dimensional Pharmacophore Design and Biochemical Screening Identifies Substituted 1,2,4-Triazoles as Inhibitors of the Annexin A2-S100A10 Protein Interaction

Regulation of fibrinolysis by S100A10 in vivo

(2011) A. P. Surette et al.   BLOOD

Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors

(2011) Leena Gandhi et al.   JOURNAL OF CLINICAL ONCOLOGY

Design, Synthesis, and Structure−Activity Relationship Exploration of 1-Substituted 4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-one Analogues as Inhibitors of the Annexin A2−S100A10 Protein Interaction

(2011) Tummala R. K. Reddy et al.   JOURNAL OF MEDICINAL CHEMISTRY

A Cy5-Labeled S100A10 Tracer Used to Identify Inhibitors of the Protein Interaction With Annexin A2

(2010) Chan Li et al.   ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

Pharmacophore-based virtual screening versus docking-based virtual screening: a benchmark comparison against eight targets

(2009) Zhi Chen et al.   ACTA PHARMACOLOGICA SINICA

Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy

(2008) Sanjeev Shangary et al.   Annual Review of Pharmacology and Toxicology

Computational chemistry approaches to drug discovery in signal transduction

(2008) Peter M. Fischer   Biotechnology Journal

Targeting the MDM2-p53 Interaction for Cancer Therapy

(2008) S. Shangary et al.   CLINICAL CANCER RESEARCH

Identification of small molecule estrogen-related receptor α-specific antagonists and homology modeling to predict the molecular determinants as the basis for selectivity over ERRβ and ERRγ

(2008) Michael J. Chisamore et al.   DRUG DEVELOPMENT RESEARCH

Sulfonamide-1,2,4-triazole derivatives as antifungal and antibacterial agents: Synthesis, biological evaluation, lipophilicity, and conformational studies

(2007) Iraj Rahavi Ezabadi et al.   BIOORGANIC & MEDICINAL CHEMISTRY